BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 11734615)

  • 1. Neurotensin and dopamine interactions.
    Binder EB; Kinkead B; Owens MJ; Nemeroff CB
    Pharmacol Rev; 2001 Dec; 53(4):453-86. PubMed ID: 11734615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin-dopamine interactions: relevance to schizophrenia and the action of antipsychotic drugs.
    Stowe ZN; Bissette G; Nemeroff CB
    Yakubutsu Seishin Kodo; 1991 Feb; 11(1):49-59. PubMed ID: 1679273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin: role in psychiatric and neurological diseases.
    Cáceda R; Kinkead B; Nemeroff CB
    Peptides; 2006 Oct; 27(10):2385-404. PubMed ID: 16891042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bidirectional regulation of dopamine D2 and neurotensin NTS1 receptors in dopamine neurons.
    Jomphe C; Lemelin PL; Okano H; Kobayashi K; Trudeau LE
    Eur J Neurosci; 2006 Nov; 24(10):2789-800. PubMed ID: 17116165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin, schizophrenia, and antipsychotic drug action.
    Kinkead B; Nemeroff CB
    Int Rev Neurobiol; 2004; 59():327-49. PubMed ID: 15006494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain neurotensin, psychostimulants, and stress--emphasis on neuroanatomical substrates.
    Geisler S; Bérod A; Zahm DS; Rostène W
    Peptides; 2006 Oct; 27(10):2364-84. PubMed ID: 16934369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
    Leonetti M; Brun P; Sotty F; Steinberg R; Soubrié P; Bert L; Renaud B; Suaud-Chagny MF
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):427-33. PubMed ID: 12070755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid desensitization of dopamine release induced by neurotensin and neurotensin fragments.
    Faggin BM; Cubeddu LX
    J Pharmacol Exp Ther; 1990 May; 253(2):812-8. PubMed ID: 2338657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurotensin/dopamine interactions].
    Kitabgi P; Hervé D; Studler JM; Tramu G; Rostène W; Tassin JP
    Encephale; 1989; 15 Spec No():91-4. PubMed ID: 2545433
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioactive analogs of neurotensin: focus on CNS effects.
    Boules M; Fredrickson P; Richelson E
    Peptides; 2006 Oct; 27(10):2523-33. PubMed ID: 16882457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.
    Labbé-Jullié C; Dubuc I; Brouard A; Doulut S; Bourdel E; Pelaprat D; Mazella J; Martinez J; Rostène W; Costentin J
    J Pharmacol Exp Ther; 1994 Jan; 268(1):328-36. PubMed ID: 8301574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurobiology of neurotensin: focus on neurotensin-dopamine interactions.
    Kasckow J; Nemeroff CB
    Regul Pept; 1991 Oct; 36(2):153-64. PubMed ID: 1666685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotensin modulates autoreceptor mediated dopamine effects on midbrain dopamine cell activity.
    Shi WX; Bunney BS
    Brain Res; 1991 Mar; 543(2):315-21. PubMed ID: 1676331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The electrophysiological effects of neurotensin on spontaneously active neurons in the nucleus accumbens: an in vivo study.
    Stowe ZN; Landry JC; Tang Z; Owens MJ; Kinkead B; Nemeroff CB
    Synapse; 2005 Dec; 58(3):165-72. PubMed ID: 16108007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain: relevance for neurodegenerative diseases and their treatment.
    Antonelli T; Fuxe K; Tomasini MC; Mazzoni E; Agnati LF; Tanganelli S; Ferraro L
    Prog Neurobiol; 2007 Oct; 83(2):92-109. PubMed ID: 17673354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do neurotensin receptor agonists represent a novel class of antipsychotic drugs?
    Cáceda R; Kinkead B; Nemeroff CB
    Semin Clin Neuropsychiatry; 2003 Apr; 8(2):94-108. PubMed ID: 12728409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotensin. Immunohistochemical localization in central and peripheral nervous system and in endocrine cells and its functional role as neurotransmitter and endocrine hormone.
    Reinecke M
    Prog Histochem Cytochem; 1985; 16(1):1-172. PubMed ID: 2859633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 5 daily injections of the neurotensin-mimetic NT69L on the expression of neurotensin receptors in rat brain.
    Wang R; Boules M; Gollatz E; Williams K; Tiner W; Richelson E
    Brain Res Mol Brain Res; 2005 Jul; 138(1):24-34. PubMed ID: 15878217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin receptors as modulators of glutamatergic transmission.
    Ferraro L; Tomasini MC; Mazza R; Fuxe K; Fournier J; Tanganelli S; Antonelli T
    Brain Res Rev; 2008 Aug; 58(2):365-73. PubMed ID: 18096238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.